QuidelOrtho Taps Masimo CFO Micah Young to Lead Financial Strategy
Event summary
- Micah Young appointed CFO of QuidelOrtho effective July 6, 2026.
- Young succeeds Joseph M. Busky, who retires but will advise during transition.
- Young brings over two decades of medical technology finance experience.
- Previously led financial strategy at Masimo Corporation from 2017 to 2026.
The big picture
QuidelOrtho's appointment of Micah Young as CFO underscores its push for stronger financial discipline amid a competitive diagnostics market. The move follows a period of transformation, signaling the company's intent to improve execution and shareholder value. Young's experience in strategic transactions and operational improvements at Masimo could be pivotal as QuidelOrtho navigates industry shifts toward more efficient diagnostic solutions.
What we're watching
- Profitability Focus
- How Young's track record at Masimo in operational improvement will translate to QuidelOrtho's profitability goals.
- Capital Allocation
- Whether Young will prioritize disciplined capital allocation similar to his approach at previous roles.
- Investor Engagement
- The pace at which Young enhances investor relations and communicates QuidelOrtho's financial strategy.